Picture EBD Group China Showcase at BTS 2021 650x81
Document › Details

ImaBiotech S.A.S.. (3/16). "Press Release: Imabiotech Obtain 6M€ for a New European Project in Partnership with Lille I University and Cubic Pharmaceuticals".

Organisations Organisation ImaBiotech S.A.S.
  Group ImaBiotech (Group)
  Organisation 2 University of Science and Technology Lille 1 (USTL) (Université Lille 1)
Products Product Multimaging™ technology (combined Mass Spectrometry Imaging and Immuno-histology, ImaBiotech)
  Product 2 drug design technology

Led by Lille I University, the application for the IMODE (Innovative MulticOmponent Drug dEsign) has been approved by the evaluation committee from the Interreg des 2 mers program. Following the Cluster AMPTEC (Avanced Materials and Pharmaceutical TECHnologies) project, this program aims to strengthen the research and development of drugs and medical devices.

The program will start on the 1st of July and last for four (4) years.

Held in partnership with Eurasanté, a French technology center, there will be several technology transfer activities and events organized over the duration of the program.

Record changed: 2016-03-28


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

More documents for ImaBiotech (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Fighting Customers 650x80px

» top